Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Disease area: Airway diseases, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
F. Verdu Rivera (Palma de Mallorca, Spain), V. Cunill Monjo (Palma de Mallorca, Spain), M. Luna Lopez (Palma de Mallorca, Spain), V. Andreu Matillas (Palma de Mallorca, Spain), A. Iglesias Coma (Palma de Mallorca, Spain), J. Pons De Ves (Palma de Mallorca, Spain), A. Alonso Fernandez (Palma de Mallorca, Spain), F. Garcia-Cosio Piqueras (Palma de Mallorca, Spain), M. Cerda Moncadas (Palma de Mallorca, Spain), J. Sauleda Roig (Palma de Mallorca, Spain). Expression of PD1, COPD and lung cancer.. 2805

Member's Comments

No comment yet.

Related content which might interest you: Increased expression of a proliferation-inducing ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: A possible link between COPD and lung cancer? Source: International Congress 2016 – Mechanisms of disease Year: 2016 Airway gene expression as a link between COPD and lung cancer Source: Annual Congress 2009 - The lung cancer-COPD nexus Year: 2009 Expression analysis of miR-223 in plasma of patients with non-small cell lung cancer and other obstructive lung diseases Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Gene expression profiles in non-small cell lung cancer (NSCLC) and lung tissue in smokers and non-smokers Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 COPD, asthma, and lung cancer patients Source: International Congress 2016 – ME13 Smoking cessation in difficult population groups Year: 2016 Expression of PARP in lung cancer: Patients with COPD and mice Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Non-small cell lung cancer resected molecular expression in COPD and low function pulmonary patients Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007 Increased sirtuin expression in patient with lung squamous cell carcinoma co-morbid with COPD Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC) Source: Virtual Congress 2020 – Endobronchial ultrasound: from rookie to pro Year: 2020 Chemokines CXCL12 and CCL21 may contribute to the development of lung cancer in COPD patients Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Reduced expression of CD44 on lung macrophages from patients with COPD Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005 Gene expression profiling in non-small cell lung cancer (NSCLC) according to smoking status Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics Year: 2008 The expression of miR185, miR29a and their targets in IPF and lung cancer (LC). A BALF study. Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways Year: 2017 WFDC2 (HE4) and SLPI are differentially expressed in normal and diseased human lung and in lung cancer Source: Annual Congress 2006 - Molecular airway biology Year: 2006 Intersections of lung progenitor cells, lung disease and lung cancer Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017 Year: 2017 Telomerase expression in idiopathic pulmonary fibrosis (IPF) and non small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Heterogeneous reactivity of ICAM-1 on alveolar macrophages (AMs) in patients with non-small cell lung cancer (NSCLC) Source: Eur Respir J 2003; 22: Suppl. 45, 256s Year: 2003 Differences in gene expression profiles in non-small cell lung cancer (NSCLC) and in corresponding healthy lung tissue in smokers and non-smokers Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer Year: 2010 Choice of endogenous control for gene expression in nonsmall cell lung cancer Source: Eur Respir J 2005; 26: 1002-1008 Year: 2005